Latest round: IPO. Jared Oasheim served as the Chief Financial Officer at CVRx, a commercial-stage medical device company specializing in neuromodulation.
Jared Oasheim served as the Chief Financial Officer at CVRx, a commercial-stage medical device company specializing in neuromodulation solutions for cardiovascular diseases. He played a key role in leading the company through its initial public offering (IPO) and establishing its financial infrastructure. Oasheim was with CVRx since 2015, contributing to the development and commercialization of Barostim, an FDA-approved medical technology for heart failure patients.
Full founder directory · Investor directory · Company funding database · Fundraising library